Olympic controversies and GLP-1 for Alzheimer's and Heart Failure

from Docs Who Lift · host Docs Who Lift

Drs. Karl and Spencer talk about the top line results from study showing liraglutide may have some benefit in Alzheimer's along with top line results from the Summit trial showing heart failure benefits with tirzepatide.They also discuss the women's boxing controversy and BMI in athletes. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Aug 7, 2024

Embed this episode

Attribution link and audio player

What this episode covers

Drs. Karl and Spencer discuss a couple of the controversies at the olympics along with the news about GLP-1 medicines treating Alzheimer's and heart failure.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Olympic controversies and GLP-1 for Alzheimer's and Heart Failure

0:00 27:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Docs Who Lift?

This episode is 27 minutes long.

When was this Docs Who Lift episode published?

This episode was published on August 7, 2024.

Can I download this Docs Who Lift episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!